Login / Signup

Identification of a DLG3 stop mutation in the MRX20 family.

Jolien HuyghebaertLigia MateiuEllen ElinckKirsten Esther Van RossemBregje ChristiaenssenClaudio Peter D'IncalMichael K McCormackAlice LazzariniGeert VandeweyerR Frank Kooy
Published in: European journal of human genetics : EJHG (2024)
Here, we identified the causal mutation in the MRX20 family, one of the larger X-linked pedigrees that have been described in which no gene had been identified up till now. In 1995, the putative disease gene had been mapped to the pericentromeric region on the X chromosome, but no follow-up studies were performed. Here, whole exome sequencing (WES) on two affected and one unaffected family member revealed the c.195del/p.(Thr66ProfsTer55) mutation in the DLG3 gene (NM_021120.4) that segregated with the affected individuals in the family. DLG3 mutations have been consequently associated with intellectual disability and are a plausible explanation for the clinical abnormalities observed in this family. In addition, we identified two other variants co-segregating with the phenotype: a stop gain mutation in SSX1 (c.358G>T/p.(Glu120Ter)) (NM_001278691.2) and a nonsynonymous SNV in USP27X (c.56 A>G/p.(Gln19Arg)) (NM_001145073.3). RNA sequencing revealed 14 differentially expressed genes (p value < 0.1) in 7 affected males compared to 4 unaffected males of the family, including four genes known to be associated with neurological disorders. Thus, in this paper we identified the c.195del/p.(Thr66ProfsTer55) mutation in the DLG3 gene (NM_021120.4) as likely responsible for the phenotype observed in the MRX20 family.
Keyphrases
  • copy number
  • genome wide
  • intellectual disability
  • genome wide identification
  • photodynamic therapy
  • single cell
  • autism spectrum disorder
  • gene expression
  • transcription factor
  • brain injury